ENDV 10-K 12/31/14

Company

ENDONOVO THERAPEUTICS, INC.

Filed

April 3, 2015

Period of Report

December 31, 2014

Accession Number

0001469709-15-000152

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →